Otsuka Pharmaceutical Co: Clinical Trials & Research Profile
Biopharma Industry (Global / Institutional) · Primary Focus: Neurology, Psychiatry, and Pain
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Global / Institutional) |
| Primary Therapeutic Area | Neurology, Psychiatry, and Pain |
| Active Phase II & III Studies | 8 active (6 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 28 |
| Completed vs Early-Stopped Studies | 18 completed / 2 stopped (7.1% stop rate) |
| Median Closed Enrollment | 176 participants |
| FDA Drugs@FDA Original Approvals | 1 all-time (1 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 97.1% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Otsuka Pharmaceutical across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk